Results 101 to 110 of about 2,202,317 (252)

Efficacy and Limitations of Quinidine in Patients With Brugada Syndrome

Circulation: Arrhythmia and Electrophysiology, 2019
Background: Quinidine at high dose is suggested as antiarrhythmic treatment in patients with Brugada Syndrome (BrS), but its efficacy to prevent life-threatening arrhythmic events (LAE) in this pop...
A. Mazzanti, E. Tenuta, M. Marino, E. Pagan, M. Morini, M. Memmi, B. Colombi, V. Tibollo, S. Frassoni, A. Curcio, C. Raimondo, A. Maltret, N. Monteforte, R. Bloise, C. Napolitano, R. Bellazzi, V. Bagnardi, S. Priori   +17 more
semanticscholar   +1 more source

Induced Brugada syndrome: Possible sources of arrhythmogenesis

Revista Portuguesa de Cardiologia, 2017
Brugada syndrome is an inherited cardiac condition with the potential for development of life-threatening arrhythmias in relatively young individuals without significant structural cardiac abnormalities. The condition is characterized by a distinct coved-
Gonçalo Tomé, João Freitas
doaj  

Time-to-first appropriate shock in patients implanted prophylactically with an implantable cardioverter-defibrillator: data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS).

Europace, 2019
Aims Data on predictors of time-to-first appropriate implantable cardioverter-defibrillator (ICD) therapy in patients with Brugada Syndrome (BrS) and prophylactically implanted ICD's are scarce.
A. Milman, A. Hochstadt, A. Andorin, J. Gourraud, F. Sacher, P. Mabo, Sung-Hwan Kim, G. Conte, E. Arbelo, T. Kamakura, T. Aiba, C. Napolitano, C. Giustetto, I. Denjoy, J. J. Juang, Shingo Maeda, Y. Takahashi, E. Leshem, Y. Michowitz, M. Rahkovich, Camilla H B Jespersen, Y. Wijeyeratne, J. Champagne, L. Calò, Zheng-rong Huang, Y. Mizusawa, P. Postema, R. Brugada, A. Wilde, G. Yan, E. Behr, J. Tfelt‐Hansen, K. Hirao, C. Veltmann, A. Leenhardt, D. Corrado, F. Gaita, S. Priori, K. Kusano, M. Takagi, P. Delise, J. Brugada, P. Brugada, G. Nam, V. Probst, B. Belhassen   +45 more
semanticscholar   +1 more source

Systematic re‐evaluation of SCN5A variants associated with Brugada syndrome

Cardiovascular Electrophysiology, 2018
A large number of SCN5A variants have been reported to underlie Brugada syndrome (BrS). However, the evidence supporting individual variants is highly heterogeneous.
N. Denham, C. Pearman, W. Ding, J. Waktare, D. Gupta, R. Snowdon, M. Hall, R. Cooper, S. Modi, D. Todd, S. Mahida   +10 more
semanticscholar   +1 more source

Bifid T waves induced by isoprenaline in a patient with Brugada syndrome [PDF]

, 1998
László Littmann
openalex   +1 more source

Diagnosis Sindrom Brugada

Majalah Kardiologi Indonesia, 2015
Brugada syndrome is an inherited autosomal dominant disease that cause sudden death, which related with mutation of SCN5A gene, ? subunit of sodium channel. The risk Brugada syndrome in male is 8 times more than females.
Edward Faisal
doaj   +1 more source

Brugada Syndrome: Progress in Diagnosis and Management

Arrhythmia & Electrophysiology Review, 2018
Brugada syndrome (BrS) represents an inherited disorder associated with risk of sudden cardiac death due to VF in patients without structural heart disease. Currently, BrS is diagnosed by typical cove-shaped ST-segment elevation >2 mm in >1 RV precordial
C. Pappone, V. Santinelli
semanticscholar   +1 more source

Use of intravenous antiarrhythmics to identify concealed Brugada syndrome [PDF]

, 2000
Ramón Brugada
openalex   +1 more source

Brugada Syndrome [PDF]

AACN Advanced Critical Care, 2012
Yuka, Mizusawa, Arthur A M, Wilde
openaire   +4 more sources

Pharmacological Therapy in Brugada Syndrome.

Arrhythmia & Electrophysiology Review, 2018
Brugada syndrome (BrS) is a cardiac disease caused by an inherited ion channelopathy associated with a propensity to develop ventricular fibrillation.
Oholi Tovia Brodie, Y. Michowitz, B. Belhassen   +2 more
semanticscholar   +1 more source